Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque



Status:Completed
Conditions:Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:May 2013
End Date:January 2016

Use our guide to learn which trials are right for you!

Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque -- A Pilot Study

This will be a pilot study of 9 patients undergoing standard-of-care clinically indicated
carotid endarterectomy. The nine patients will receive an injection of Indocyanine green
(ICG) at a dose of 0.25 mg/kg (maximum 25 mg) as an intravenous bolus.

Immediately following endarterectomy, the resected specimen will be immersed in normal
saline. Ex vivo fluorescence reflectance imaging (FRI) and immunohistochemistry will be
performed.

The investigators hypothesize that compared to controls, ICG-injected patients will
demonstrate increased ex vivo and microscopic ICG fluorescence signal within areas of
plaque.


Inclusion Criteria:

- Consecutive patients scheduled for elective carotid endarterectomy at Massachusetts
General Hospital

- Age > 18 years of age.

- Signed informed consent.

Exclusion criteria:

- Hemodynamic instability

- Any history of iodide allergy

- Any history of renal failure (estimated Glomerular Filtration Rate (eGFR) <50
ml/min/1.73 m2)

- Any history of liver failure

- Any history of bleeding diathesis

- Any history of cerebral vascular accident in the preceding 3 months

- Pregnant or lactating females.

- Hx of seafood allergy
We found this trial at
1
site
185 Cambridge Street
Boston, Massachusetts 02114
617-724-5200
?
mi
from
Boston, MA
Click here to add this to my saved trials